OUR LATEST UPDATE:  Biocoat Incorporated Announces Strategic Investment by GTCR … READ MORE

BiocoatIncR_Logo-FINAL transparent back

WE’RE HERE FOR YOU

About Us

OUR MISSION

Our mission is to provide customized surface technology solutions by combining best-in-class quality and customer service to support the development of medical devices that aid in improving patient outcomes.

We are a global leader in the development, manufacturing and application of hydrophilic (slippery) coatings used in medical devices. Our hydrophilic coatings allow for medical devices to easily traverse through the body by minimizing friction as the material moves to its intended destination. Our custom hydrophilic coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates.

0
Years of Partnerships
0
Countries covered worldwide
2015
ISO 13485:2016 Certified

Facilities & Locations

Biocoat headquarters are located in Horsham, PA, about 45 minutes outside of Philadelphia, PA. In May 2018, Biocoat officially opened our new facility at Rock Road, bringing our total square footage to 46,600 square feet. Biocoat has six ISO 7 cleanrooms, manufacturing, R&D and disaster recovery facilities all dedicated to the development and expert application of our hydrophilic coatings.

Our Leadership

The strength of an organization lies in its people. The team of experts at Biocoat, and its Board of Directors, is made up of leaders in the industry, clinical champions and innovative thinkers.

Leadership Team

Board of Directors

Executive Team

Jim Moran

President & CEO

Steven Bell

Chief Financial Officer

Dr. Robert Hergenrother

Vice President, Research, Development and Innovation

Thomas Brugnoli

Vice President of Operations

Heather L.A. Hennessey

Director, Quality Assurance & Regulatory Affairs

Leadership Team

Joe Sandora

Vice President, Business Development

Dhruv Patel

Senior Director, Business Development, Coating Equipment

Joshua de Freitas

Director, Business Development

 Lisa Korndoerfer

Controller

Mark Eberhardt

Senior Director, Marketing

Tommy Cataldi

Director, Human Resources

Scott Crammer

Chairman of the Board President & CEO, DNA Diagnostics Center

Michael Koby

Founding Partner, 1315 Capital

Matt Bastardi

SVP, Commercial & Strategy, Surgical Specialties Corporation

Wes Kaupinen

President and CEO, Palvella Therapeutics

Jim Moran

President & CEO, Biocoat

2022
Biocoat, Incorporated Announces Strategic Investment By GTCR
2022
Introduction Of EMERSE Dip Coating System

Biocoat introduces EMERSE Dip Coating System our new hydrophilic dip coating equipment line

2021
Celebrating Our 30th Year Of Developing Hydrophilic Coatings!
2020
Introduction Of HYDAK® UV

Biocoat introduces a new UV cured version of our HYDAK coatings.

2019
Grand Opening Of Coating Services Unit

To read more about our Coating Services, visit our Custom Coating Solutions section in the main navigation.

2019
ISO Certified

Biocoat receives its ISO 13485:2016 certification.

2018
1315 Capital Acquires Biocoat

Biocoat celebrates its renewed mission to offer industry-leading custom coating solutions with its acquisition by 1315 Capital.

2018
Grand Opening & A Renewed Mission

The Rock Road facility opens, bringing the company’s total square footage to over 62,000 square feet.

2017
A Brand New Look

Biocoat undergoes a complete rebranding, better reflecting the cutting-edge technology they offer their medical device partners.

2016
Groundbreaking On A New Home

Construction of Biocoat state-of-the-art Rock Road headquarters begins in Horsham, PA. The new facility, in combination with the original Witmer Road facility, means over 62,000 square feet of production capacity.

2007
PICSI® Device Released

Biocoat releases the revolutionary PICSI® Sperm Selection Device.

2005
The Move To Horsham

Biocoat headquarters officially moves from Beaver College to its new home on Witmer Road in Horsham, PA.

2004
HBA® Released

Biocoat proprietary Hyaluronan Binding Assay (HBA) is released to the medical device market.

2003
An End Of An Era

Ellington Beavers, visionary and founder of Biocoat, retires.

1994
First Products Are Licensed

Two companies license Biocoat products for commercial use.

1991
Company Is Founded

By Ellington Beavers at Beaver College (present day Arcadia University)

Interested in a Hydrophilic Coating Solution?

Our team of engineers and coating experts would be glad to have a discussion about your project and its requirements.
Img1 300 x 300

Lisa Korndoerfer

Controller

Lisa Korndoerfer joined Biocoat in 2017 as the Controller. In this role, Lisa is responsible for and oversees the Finance Department.

Lisa brings 23 years of accounting experience, which she obtained from working at public accounting firms, manufacturing, and software companies.

Lisa holds a Bachelor of Science in Accounting from the University of Hartford.
Img2 300 x 300

Mark Eberhardt

Senior Director of Marketing

Mark Eberhardt is the Senior Director of Marketing for Biocoat, a position he has held since 2018.  Mark is responsible for the overall maintenance and exposure of the Biocoat brand.  
 
Mark has over 25 years of experience in Marketing in the pharmaceutical, biotechnology, and medical device industries and previously worked at Ergomed, Pharm-Olam, ICON plc, Drug Information Association (DIA), and Lippincott Williams & Wilkins.  Mark received a Master of Business Administration degree from the University of Phoenix and a Bachelor of Science degree from Misericordia University.  
leadership

Tommy Cataldi

Director, Human Resources

Thomas (Tommy) Cataldi is the Director of Human Resources for Biocoat. In his role, he is responsible for oversight of the “people” side of our business, which includes all HR administrative functions.

Tommy joined Biocoat in 2021 with over 20 years of experience in HR and 11+ years leading an HR department.  He has a history of achievement of building HR from the ground up in U.S. and non-U.S. locations, along with proven success integrating employees after M&As.  His background includes work at multi-international companies and companies that specialize in engineering and/or sciences.

Tommy received a Bachelor of Arts in English Literature from West Chester University, a Master of Business Administration (MBA) from Clemson University and HR Certification from Villanova University.  He received his Senior Professional in Human Resources (SPHR) designation in 2003. 

Josh-de-Freitas

Joshua de Freitas

Director, Business Development

Joshua de Freitas is the Director of Business Development for Coating Products and Services. In this role, Josh is responsible for guiding Biocoat customers in coating design, development, and commercialization.

Josh joined Biocoat in 2020 after spending nearly 10 years in leadership and commercial positions supporting the medical device industry with roles at TE Connectivity and DSM Biomedical. Josh started his professional career serving 11 years as a US Army Officer and Medical Evacuation Helicopter Pilot with assignments around the globe.  

Josh holds a Bachelor of Arts degree from the University of Delaware and a Master of Business Administration degree from the University of South Carolina.

Dhruv Patel

Senior Director, Business Development, Coating Equipment

Dhruv Patel is the Senior Director of Business Development, Coating Equipment for Biocoat. In this role, Dhruv is responsible for leading Biocoat customers in the design, development, and hydrophilic coating equipment.

Dhruv joined Biocoat in 2009 and holds a Bachelor of Science degree from the University of Mumbai, and two Masters degrees, one in Biomedical Engineering from the New Jersey Institute of Technology and the other in Business Administration from Villanova University.

Jim Moran

President & CEO, Biocoat

Jim Moran is the President and CEO of Biocoat, Inc, a position he has held since 2018. Jim has been in the medical industry for over 25 years in various leadership, sales and marketing roles in both domestic and international assignments. Prior to joining Biocoat, he worked at Bracco Diagnostics, Acclarent, ConvaTec, TaylorMade-adidas Golf, Songbird Hearing and Vistakon. Jim also founded his own privately held medical device company called Jazz Medical in 2012 to provide advanced wound care products to the veterinary market.

Jim received a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Marketing from St. Joseph’s University in Philadelphia.

Wes Kaupinen

President and CEO, Palvella Therapeutics

Wes Kaupinen has been on the Biocoat Board since 2017 and is the President and CEO of Palvella Therapeutics. Wes has an extensive background in M&A, business development, and capital raising, having spent time an as investment banker, venture capital investor and senior executive at a publicly traded life sciences company. Wes has extensive networks in the cardiovascular, neurovascular, peripheral vascular, ophthalmic markets as well as in the private equity arena.

Wes has an MBA degree from the Wharton School at University of Pennsylvania and a B.A. from the University of Virginia.

Matt Bastardi

SVP, Commercial & Strategy, Surgical Specialties Corporation

Matt has held senior level positions within multi-national and emerging growth medical device & diagnostics companies. His experience spans corporate development, strategic planning, sales, marketing, finance, and general management leadership roles for branded products and contract manufacturing businesses.

Currently, he is Senior Vice President, Commercial & Strategy for Surgical Specialties Corporation. Previously, Matt held various positions with Accriva Diagnostics, Covidien, Flex, and Accellent.

Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Science degree in Business from Georgetown University.

Michael Koby

Founding Partner, 1315 Capital

Michael Koby co-founded 1315 Capital in 2014, after spending his entire career as a healthcare investor and operator, including experience with more than 25 growth equity investments. Prior to founding 1315 Capital, Michael was a Managing Director at Palm Ventures, a private-equity focused family office where he led all healthcare investing. While at Palm, Michael led investments in Enigma Diagnostics, Axcentria Pharmaceuticals, and JDS Therapeutics. He currently serves on the boards of Biocoat, Centurion Service Group, CHC Solutions, JDS Therapeutics, and Solsys Medical.

Before Palm Ventures, Michael spent over a decade as an investor, including before and after business school, at Galen Partners, a healthcare growth equity investment firm. He also held business development roles at Novoste Corporation and Medtronic, Inc. Michael started his career as a healthcare investment banking analyst at Dillon, Read & Co.

Michael received a BSc from Cornell University and an MBA in Healthcare Management from The Wharton School.

Scott Crammer

Chairman of the Board President & CEO, DNA Diagnostics Center

Scott has over 30 years’ experience and is a proven and focused medical device & diagnostics CEO. He has significant experience driving change by instilling a culture of high performance and implementing growth strategies as well as operational improvement initiatives, resulting in a track-record of successful exits.

Scott has served in executive level positions at Accriva Diagnostics, Warburg Pincus, Novasys Medical, Bacchus Vascular, VNUS Medical, EndoSonics (Volcano Corporation), Cardiometrics and Baxter Healthcare Corporation.

Scott holds a B.S. degree in Finance from Philadelphia University.

Heather-Hennessey---High-Res

Heather L.A. Hennessey

Director, Quality Assurance & Regulatory Affairs

Heather L.A. Hennessey is the Director of Quality Assurance & Regulatory Affairs, and Management Representative for Biocoat. In her role, Heather is responsible for oversight of the Quality Assurance and Quality Control groups, as well as ensuring overall quality and regulatory compliance for the entire organization.

Heather joined Biocoat in 2020 and has a 20 year track record of success in compliance remediation, driving out inefficiencies, and implementing change and continuous improvement at such companies as Polysciences, Regeneron, The Secant Group, Cenveo, AstraZeneca (Medimmune), and Day & Zimmermann International.

Heather received a Bachelor of Science in Biology from Stockton University and is a certified ISO 13485:2016 Lead Auditor.

Joe Sandora

Vice President, Business Development

Joe Sandora joined Biocoat in 2018 as Vice President of Business Development. In his role, Joe has been responsible for all domestic and international strategic relationships, contract negotiations and corporate sales strategy.

He has over 25 years in business development and senior sales management in the medical device industry having previously been with Devon Medical Products, Georgia-Pacific Professional, and ConvaTec- A Bristol Myers Squibb Company.

Joe holds a Bachelor of Arts degree from St. Lawrence University.

Thomas Brugnoli

Vice President of Operations

Thomas (Tom) Brugnoli is Biocoat Vice President of Operations. Tom joined Biocoat in 2019 to lead the design and management of the Contract Coating Services unit. Tom is also responsible for the manufacturing of all coating reagents.

Tom has over 30 years of manufacturing experience which he obtained from prior operations, manufacturing and engineering services positions at Bristol-Myers Squibb and ConvaTec.

Dr. Robert Hergenrother

Vice President, Research, Development and Innovation

Dr. Robert (Bob) Hergenrother is Biocoat Vice President of Research, Development and Innovation. In this role, Bob leads the research team in the development, maximization and exploration of new products and coating methodologies.

Bob joined Biocoat in 2017 after spending nearly 25 years in research and development roles at the Southern Research Institute, Surmodics and Boston Scientific. Bob was also a Professor in the Department of Biomedical Engineering at the University of Alabama at Birmingham.

Bob holds a Bachelor of Science degree from the University of Notre Dame and a PhD in Chemical Engineering from the University of Wisconsin-Madison.

Steven Bell

Chief Financial Officer

Steven (Steve) Bell is Biocoat Chief Financial Officer. As CFO, Steve provides executive oversight of Biocoat financial and technology functions. Steven joined Biocoat in 2019 and brings 35 years of business experience that he obtained while working as a Certified Public Accountant and also as a CFO at ReSearch Pharmaceutical Services, CareScience, The MRC Group, and as a consultant providing outsourced CFO services for various middle market companies.

Steve received a Bachelor of Business Administration (BBA), Accounting from Temple University.

Jim Moran

President & CEO

Jim Moran is the President and CEO of Biocoat, Inc, a position he has held since 2018. Jim has been in the medical industry for over 25 years in various leadership, sales and marketing roles in both domestic and international assignments. Prior to joining Biocoat, he worked at Bracco Diagnostics, Acclarent, ConvaTec, TaylorMade-adidas Golf, Songbird Hearing and Vistakon. Jim also founded his own privately held medical device company called Jazz Medical in 2012 to provide advanced wound care products to the veterinary market.

Jim received a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Marketing from St. Joseph’s University in Philadelphia.

Let’s Connect

Our team of engineers and clinical experts would be glad to have a discussion about your project and its requirements.
By submitting this form you acknowledge that you have reviewed our privacy policy and understand how we are using your information. reCAPTCHA helps prevent automated form spam. The submit button will be disabled until you complete the CAPTCHA.